Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NV/Reno
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Reno, NV

Studies commonly pay $75 to $4,500 per completed study

202 clinical trials are currently recruiting participants within 30 miles of Reno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

202studies recruiting
4+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Reno right now

Top 25 of 202 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Non-small Cell Lung Cancer Phase 3 Interventional 1,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT06561386)

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Breast Cancer Phase 3 Interventional 400 participants sought
Renown Health Medical Oncology — Reno, Nevada (2.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07062965)

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

Chronic Idiopathic Constipation (CIC) Phase 3 Interventional 692 participants sought
Advanced Research Institute - Reno — Reno, Nevada (2.3 mi) · Sponsor: Ardelyx
See eligibility & contact on ClinicalTrials.gov (NCT07382167)

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

Diabetic Retinopathy Phase 2, Phase 3 Interventional 576 participants sought
Sierra Eye Associates /ID# 274737 — Reno, Nevada (2.3 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07592273)

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer Phase 3 Interventional 186 participants sought
Center of Hope — Reno, Nevada (2.3 mi) · Sponsor: Genelux Corporation
See eligibility & contact on ClinicalTrials.gov (NCT05281471)

Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation

Head and Neck Cancer N/A Interventional 30 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Renown Health
See eligibility & contact on ClinicalTrials.gov (NCT07160296)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Gene Upshaw Memorial Tahoe Forest Cancer Center — Truckee, California (23.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Retroperitoneal Sarcoma, Liposarcoma Phase 3 Interventional 250 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
See eligibility & contact on ClinicalTrials.gov (NCT04031677)

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Cigarette Smoking-Related Carcinoma Phase 3 Interventional 600 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05008848)

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Multiple conditions Phase 2 Interventional 98 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06532279)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum N/A Interventional 9,500 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05080673)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation, HER2- Negative Breast Cancer Phase 3 Interventional 540 participants sought
Renown Health Medical Oncology — Reno, Nevada (2.3 mi) · Sponsor: Relay Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06982521)

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Multiple Myeloma Phase 3 Interventional 1,060 participants sought
Renown Health Medical Oncology — Reno, Nevada (2.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05623020)

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

Glioblastoma Phase 3 Interventional 741 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: NovoCure GmbH
See eligibility & contact on ClinicalTrials.gov (NCT06556563)

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Pancreatic Carcinoma, Pancreatic Neoplasm Phase 3 Interventional 274 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06807437)

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Geographic Atrophy Secondary to Age-related Macular Degeneration N/A Observational 75 participants sought
Sierra Eye Associates — Reno, Nevada (2.3 mi) · Sponsor: Complement Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07144137)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer Phase 3 Interventional 230 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT05894239)

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Liver Neoplasms, Primary Liver Cancer N/A Observational 5,000 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: HistoSonics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06486454)

Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism

Hypoparathyroidism, Chronic Hypoparathyroidism Phase 3 Interventional 160 participants sought
Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site — Reno, Nevada (2.3 mi) · Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company
See eligibility & contact on ClinicalTrials.gov (NCT07805356)

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Metastatic Breast Cancer Phase 1, Phase 2 Interventional 1,132 participants sought
Renown Regional Medical Center — Reno, Nevada (2.3 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT03424005)
Actively enrolling

Studies you may be able to join near Reno

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Reno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Allied Clinical Research

236 W 6th St Unit 307, Reno, NV 89503
(775) 800-6999

Renown Health Office of Clinical Research

75 Pringle Way Ste 801C, Reno, NV 89502
(775) 982-3646

Center for Molecular Medicine

★ 5.0
0357, 1664 N Virginia St, Reno, NV 89557
(775) 784-6001
"Fantastic institute for Physiology and Cell Biology School of Medicine."
— Rajan Singh, 5★

Advanced Research Institute-Reno

★ 5.0
655 Sierra Rose Dr, Reno, NV 89511
(775) 502-1616
"Lovely staff who are doing important work for patients"
— Ally LaBorde, 4★

Clinical trials in Reno: what's recruiting

The Reno area currently has 202 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Reno, the most active research areas are:

  • Cancer & Oncology19 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Reno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Reno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Reno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Reno pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Reno?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Reno safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Reno, NV?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Reno?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.

Paid clinical trials near Reno

Other metros within reach

Roseville, CA643 Sacramento, CA642 Elk Grove, CA631 Stockton, CA107 Modesto, CA106 Merced, CA27 Antioch, CA463 Fairfield, CA350

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Reno Bladder Issues Due To Spinal Cord Injury in Reno All conditions

More of NV

Las Vegas453 Henderson453 North Las Vegas453 Enterprise453 Spring Valley453 Sunrise Manor453 Paradise453

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts